SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-177917
Filing Date
2013-04-26
Accepted
2013-04-26 16:42:38
Documents
7
Period of Report
2013-06-12
Effectiveness Date
2013-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d524520ddef14a.htm DEF 14A 974691
2 GRAPHIC g524520g00f33.jpg GRAPHIC 14595
3 GRAPHIC g524520g04d24.jpg GRAPHIC 9473
4 GRAPHIC g524520g11p38.jpg GRAPHIC 25502
5 GRAPHIC g524520g33r49.jpg GRAPHIC 41262
6 GRAPHIC g524520g38v97.jpg GRAPHIC 18234
7 GRAPHIC g524520g76c13.jpg GRAPHIC 31574
  Complete submission text file 0001193125-13-177917.txt   1170386
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33103 | Film No.: 13787920
SIC: 2834 Pharmaceutical Preparations